The study investigated whether ␤-adrenoceptor antagonists augment the hypertrophic response of cardiomyocytes evoked by norepinephrine. BACKGROUND In adult ventricular cardiomyocytes, stimulation of ␣-but not ␤-adrenoceptors induces myocardial hypertrophy. Natural catecholamines, like norepinephrine, stimulate simultaneously ␣-and ␤-adrenoceptors. We investigated whether ␤-adrenoceptor stimulation interferes with the hypertrophic response caused by ␣-adrenoceptor stimulation.
Increased plasma levels of catecholamines are commonly found under conditions leading to myocardial hypertrophy (1, 2) . Selective stimulation of ␣ 1 -adrenoceptors, but not of ␤-adrenoceptors, increases cellular synthesis of protein and RNA in adult ventricular cardiomyocytes, which represent hallmarks of myocardial hypertrophy (3) (4) (5) . Natural catecholamines stimulate both ␣ 1 -and ␤ 1 -adrenoceptors on ventricular cardiomyocytes. It is as yet unknown whether, in adult ventricular cardiomyocytes under simultaneous stimulation of ␣ 1 -and ␤-adrenoceptors, the ␤-adrenoceptor stimulation can modulate the hypertrophic response to ␣ 1 -adrenoceptor stimulation. This question was addressed in the study presented here.
A well-defined experimental model of cultured adult ventricular cardiomyocytes from rats was used (4) . Ventricular cardiomyocytes from adult rats have previously been shown to possess functionally coupled ␤ 1 -adrenoceptors (6); whether or not they also contain (few) ␤ 2 -adrenoceptors is still a matter of debate (6, 7) . They also express functional ␣ 1 -adrenoceptors but not ␣ 2 -adrenoceptors (8) .
Four series of experiments were performed. In the first series, the natural catecholamine norepinephrine, the main transmitter of the sympathetic nervous system, was used. Norepinephrine has a high affinity for ␣ 1 -and ␤ 1 -but not ␤ 2 -adrenoceptors. It was tested if its effect on phenylalanine incorporation can be modified i) by presence of the ␤-adrenoceptor antagonist propranolol, ii) by the presence of the ␤ 2 -adrenoceptor antagonists CPG 20712A or atenolol, or iii) by the presence of the ␤ 2 -adrenoceptor antagonist ICI 118,551. In the second series of experiments, the effect of atenolol on the hypertrophic effect of norepinephrine was compared to the response of selective ␣ 1 -adrenoceptor stimulation by phenylephrine. In addition to phenylalanine incorporation, effects on protein and RNA mass and cell volume were determined. In the third series of experiments, selective ␣ 1 -adrenoceptor stimulation by phenylephrine was combined with stimulation of ␤-adrenoceptors or addition of dibutyryl-cyclo-AMP, to mimic ␤-adrenoceptor stimulation. In the fourth series of experiments, some of the experiments of the first series were repeated on cardiomyocytes isolated from hypertrophic myocardium of rats submitted to aortic banding.
METHODS
Falcon tissue culture dishes were obtained from BectonDickinson (Heidelberg, Germany). Boehringer Mannheim (Mannheim, Germany) was the source for glutamine-free medium 199 and fetal calf serum (FCS). Cytsosine-␤-Darabinofuranoside, L -carnitine, creatine, taurine, l-phenylephrine hydrochloride, dl-isoproterenol hydrochloride, phorbol 12-myristate 13-acetate, procaterol, atenolol, and dibutyryl-cyclo-AMP were obtained from Sigma (Deisenhofen, Germany). l-Norepinephrine bitartrate was purchased from Serva (Heidelberg, Germany). The ICI 118,551 hydrochloride and CPG 20712A methasulfonate were obtained from RBI/Sigma (Deisenhofen, Germany). All other chemicals were of analytical grade. Cell culture. Ventricular heart muscle cells were isolated from 200-g to 250-g male Wistar rats as previously described (9, 10) . Isolated cells were suspended in fetal calf serum-free culture medium and plated at a density of 1.4 ϫ 10 5 elongated cells/35-mm culture dish (Falcon type 3001; 14 C-phenylalanine experiments) or 1.6 ϫ 10 4 elongated cells/22 mm culture dish (Falcon type 3815, 3 Hphenylalanine experiments). The culture dishes had been preincubated overnight with 4% FCS in medium 199 to allow cell attachment (9) . The basic culture medium consisted of medium 199 with Earle's salts, 5 mmol/liter creatine, 2 mmol/liter L-carnitine, 5 mmol/liter taurine, 100 IU/ml penicillin, and 100 g/ml streptomycin. To prevent growth of nonmyocytes, media were also supplemented with 10 mol/liter cytosine-␤-D-arabinofuranoside.
Four hours after plating, cultures were washed twice with culture medium to remove round and nonattached cells and supplied with FCS-free experimental media, in which cells were incubated for a 24-h period at 37°C. The experiments were carried out in basic culture medium (control), with additions of norepinephrine, phenylephrine, isoprenaline, atenolol, ICI 118,551, or dibutyrl-cyclo-AMP, at concentrations indicated. Ascorbic acid (100 mol/liter) was added to all cultures as an antioxidant. Incorporation of phenylalanine and uridine and changes in cellular protein and RNA mass. Incorporation of phenylalanine into cells was determined by exposing cult u r e s t o [
3 H ] p h e n y l a l a n i n e ( 0 .
14 C]phenylalanine (0.1 Ci/ml) for 20 to 24 h (11), and the incorporation of radioactivity into acid-insoluble cell mass was determined as described previously (4) . We showed before that the incorporation of phenylalanine into cell protein is linear within the first 36 h (12) . Nonradioactive phenylalanine (0.3 mmol/liter) was added to the medium to minimize variations in the specific activity of the precursor pool responsible for protein synthesis. Protein contents (13) and DNA contents (14) were determined according to previous reports. The RNA content was determined according to an earlier study (15) .
Incorporation of uridine into cells was determined as described previously (12) by exposing cultures to L-[ 14 C]uridine (0.1 Ci/ml) for 6 h and the incorporation of radioactivity into acid-insoluble cell mass was calculated. The radioactivity was determined in the aliquots used to quantify RNA mass as described above. We showed before that the incorporation of 14 C-uridine into RNA is linear within the first 6 h (12). Determination of cell volume and cross-sectional area. Myocyte growth was determined on phase-contrast micrographs recorded on tape using a CCD-video camera. Cell volumes were calculated by the following formula: Volume ϭ (radius) 2 * * length, assuming a cylindrical cell shape. Cross-sectional area was determined by the following formula: cross-sectional area ϭ (radius) 2 *. Aortic banding. Aortic banding was performed in four week-old male Wistar-Kyoto rats exactly as recently described (16) . Briefly, animals were anesthetized and the aorta was exposed through a midline abdominal incision distal to the coastal arch at the left side. The aorta was constricted with a cutton threat just proximal to the renal artery using a blunt wire (diameter 1 mm) to establish the diameter of the ligature. Subsequently, after infusing a solution of penicillin/streptomycin combination (Tardomyocel comp. III, Bayer AG, Leverkusen, Germany; 0.1 ml/kg) in the retroperitoneal cavity, the muscle layers were closed with absorbable suture and the skin with atraumatic silk suture. Controls were sham-operated, without placing the stenosis around the aorta. Both groups of animals were kept under the same condition and were used for experiments eight weeks after surgical interventionthat is, at 12 weeks of age. On the day of experiments, rats with an aortic banding and age-matched, sham-operated animals were anesthetized with pentobarbitone. The right carotid artery and the femoral artery were cannulated, and arterial pressure proximal and distal to the aortic constric- 
Beta-vs. Alpha-Adrenoceptor Cross Talk tion was measured with a pressure transducer (model W112, Hugo Sachs Electronic KG, Freiburg, Germany). The systolic blood pressure (carotid arterial pressure) in aortic banding rats (169 Ϯ 13 mm Hg, n ϭ 10) was significantly higher than in sham-operated animals (124 Ϯ 9 mm Hg, n ϭ 10). Differences between pre-and post-stenotic blood pressure measured in the carotid and the femoral artery were 52 Ϯ 11 mm Hg (n ϭ 10) in aortic banding rats and 1 Ϯ 2 mm Hg (n ϭ 10) in sham-operated animals. Protein kinase C translocation. As a parameter of protein kinase C (PKC) activation its translocation into the particular fraction was investigated. Cardiomyocytes were treated for 5 min with norepinephrine with or without pretreatment with atenolol. Thereafter, the cultures were washed twice with ice-cold phosphate buffered solution (PBS), scraped off in PBS and centrifuged for 2 min at 12,000 g. The remaining pellet was redissolved in 100 l of lysis buffer (composition in mmol/liter: Tris 20, EGTA (ethylene glycol-bis (␤-amino ethyl ether) N,N,NЈ,NЈ-tetraacetic acid) 10, EDTA 2, sucrose 200, PMSF (phenylmethyl sulfononyl fluoride) 0.01, pH 7.4) and stored at Ϫ20°C. Thereafter, the solution was mixed vigorously and centrifuged again for 1 h at 38,000 g. The remaining pellet was used as the particular fraction, redissolved in 100 l lysis buffer to which Triton X-100 was added (final concentration 0.1% [v/v]). The solution was incubated again for 2 h at 4°C. Thereafter, the solution was centrifuged again for 15 min with 12,000 g at 4°C. This supernatant was mixed with 20 l Laemmli buffer. The samples were heated for 5 min at 95°C and used for gel electrophoresis. The samples were loaded on a 12.5% SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and after electrophoretic separation they were transferred on an immobilon-P membrane (Millipore, Bedford, Massachusetts). The bands were visualized and immunoblotted against antibodies directed against PKC-␣ and PKC-␦. The intensity of the final bands was analyzed densitometrically using Image-Quant software. Statistics. Data are given as means Ϯ SEM from a different culture preparations. Statistical comparisons were performed by one-way analysis of variance (ANOVA) and use of the Student-Newman-Keuls test for post hoc analysis (17) . Differences with p Ͻ 0.05 were regarded as statistically significant.
RESULTS
Influence of ␤-adrenoceptor antagonists on phenylalanine incorporation in the presence of norepinephrine. Norepinephrine (0.01 to 10 mol/liter) caused concentration-dependent increases in phenylalanine incorporation (Fig. 1) . The increase at 10 mol/liter was about 45% above control, and the pEC 50 -value was 5.9 Ϯ 0.1 (n ϭ 8). The ␣ 1 -adrenoceptor antagonist prazosin (0.1 mol/ liter) significantly suppressed norepinephrine-induced increase in protein synthesis (Fig. 1A) . In contrast, the ␤-adrenoceptor antagonist propranolol (1 mol/liter) significantly enhanced norepinephrine-induced increase in rate of protein synthesis (Fig. 1B) . To study which ␤-adrenoceptor subtype might be involved in this suppression of norepinephrine-induced protein synthesis, experiments with the selective ␤ 1 -adrenoceptor antagonist CPG 20712A (300 nmol/liter) and the selective ␤ 2 -adrenoceptor antagonist ICI 118,551 (55 nmol/liter) were performed as shown in Figure 2 . Both CPG 20712A and ICI 118,551 were used in concentrations at which they occupy less than 5% of ␤ 2 -adrenoceptors or less than 10% of ␤ 1 -adrenoceptors, respectively (18) . In the presence of CPG 20712A, norepinephrine-induced phenylalanine incorporation was significantly enhanced, whereas ICI 118,551 did not affect it. Similar to CGP 20712A, the selective ␤ 1 -adrenoceptor antagonist atenolol (1 mol/liter) significantly augmented norepinephrine-induced increase in phenylalanine incorporation (Fig. 3) . Influence of atenolol on the hypertrophic responses caused by norepinephrine. The effects of phenylephrine (10 mol/liter), norepinephrine (1 mol/liter), or norepinephrine plus atenolol (1 mol/liter) were compared in the next exper- imental series. Phenylephrine increased phenylalanine incorporation by 34%. Norepinephrine increased it by 22% in the absence and by 42% in the presence of atenolol (Fig. 4) . The 24-h change in cellular protein mass, measured as protein/ DNA ratio, was also determined (Fig. 4) . Phenylephrine increased protein mass by 27%; norepinephrine alone had no significant effect. When norepinephrine was applied in the presence of atenolol, it caused an increase in protein mass (20%) comparable to that with phenylephrine. The RNA synthesis in cardiomyocytes was estimated by determination of the 6-h incorporation of uridine into RNA (Fig. 5) . In the presence of phenylephrine (10 mol/liter), uridine incorporation was increased by 25%, and in the presence of norepinephrine (1 mol/liter) by only 13%. When norepinephrine was administered in the presence of atenolol (1 mol/liter), the increment in uridine incorporation became comparable to that seen in presence of phenylephrine. Similar changes were seen when the 24-h increase in total RNA mass, determined as RNA/DNA ratio, was measured (Fig. 5) . Phenylephrine increased RNA mass by 13%, norepinephrine by only 7%, but norepinephrine combined with atenolol by 13%.
The influences on cell shapes of either norepinephrine or norepinephrine plus atenolol were also investigated. Compared to untreated control cells, norepinephrine (1 mol/ liter) increased cell volume by 6.4%; norepinephrine plus atenolol, however, increased it by 36.1% (Table 1) . Crosssectional area of the cells was increased by 16 .0% compared to untreated control cells in the presence of norepinephrine, and by 46.0% in the presence of norepinephrine plus atenolol. Figure 6A , atenolol augmented the norepinephrine-induced translocation of PKC-␣ and -␦ isoforms into the particulate fraction. The hypertrophic effects evoked by the selective ␣-adrenoceptor agonist phenylephrine (10 mol/liter) were significantly reduced by ␤ 1 -adrenoceptor stimulation (isoprenaline plus ICI 118,551) (Fig. 6B) . In contrast, selective stimulation of ␤ 1 -adrenoceptors did not antagonize the hypertrophic response evoked by direct stimulation of PKC-that is, by addition of phorbol myristate acetate (PMA, 100 nmol/ liter) (Fig. 6B) . Therefore, we conclude that stimulation of ␤ 1 -adrenoceptors attenuates the activation of PKC caused by ␣-adrenoceptor stimulation.
The inhibitory effect of ␤-adrenoceptor stimulation on the initiation of protein synthesis was also studied in another set of experiments in which endothelin-1 (10 nmol/liter) was used to stimulate protein synthesis. These experiments were performed to investigate whether the inhibitory effect of ␤-adrenoceptor stimulation on protein synthesis can also be demonstrated for other agonists that stimulate protein synthesis via PKC activation. The hypertrophic effect evoked by endothelin (increase in phenylalanine incorporation to 119 Ϯ 5%, p Ͻ 0.01 vs. control, n ϭ 7) was blunted in co-presence of isoprenaline (93 Ϯ 6%, p Ͻ 0.01 vs. endothelin alone, n ϭ 7).
It was further investigated whether this inhibitory effect of ␤ 1 -adrenoceptor stimulation is cAMP (cyclic adenosine monophosphate) dependent. Therefore, we performed experiments in which the ␤ 1 -adrenoceptor-mediated inhibitory effect was antagonized on the postreceptor level by addition of Rp-cAMPS (adenosine-3Ј, 5Ј-cyclic phosphorothiolate-Rp), which augmented the hypertrophic response caused by norepinephrine. At 1 mol/liter, norepinephrine did not affect protein synthesis. However, in co-presence of Rp-cAMPS phenylalanine incorporation was increased by 42% (Fig. 7) . In addition, Rp-cAMPS also augmented the hypertrophic response evoked by phenylephrine in the presence of isoprenaline and ICI 118,551. In the presence of isoprenaline and ICI 118,551, phenylalanine increased protein synthesis by only 4%, but in co-presence of Rp-cAMPS this response was augmented to 38% (Fig. 7) . Finally, the hypertrophic effect evoked by phenylephrine was markedly reduced by addition of dibutyrl-cyclic AMP (Fig. 7) . Influence of ␤-adrenoceptor antagonists on phenylalanine incorporation in the presence of norepinephrine in hypertrophied cardiomyocytes. In a last set of experiments, it was investigated whether the inhibitory effect of ␤ 1 -adrenoceptor stimulation on the ␣-adrenoceptor- mediated growth effect is preserved in cardiomyocytes isolated from hearts with hypertrophy and ␤-adrenoceptor desensitization. For this purpose, cardiomyocytes from rats that had received aortic constriction for eight weeks were isolated, and growth response to norepinephrine was investigated in the absence and presence of propranolol. Hearts from rats that had undergone aortic banding showed increased left ventricular weight compared to sham-operated animals (Table 2A ). In ventricular myocardium of these rats, activation of left ventricular adenylyl cyclase by isoprenaline was significantly reduced compared to shamoperated animals (Table 2A) , indicating a desensitization of ␤-adrenoceptors. Similarly, the maximal increase in force of contraction of electrically driven left ventricular strips induced by isoprenaline was significantly lower than in strips of sham-operated animals (16) . Cardiomyocytes isolated from animals with aortic banding showed a lower norepinephrine-induced increase in protein synthesis compared to those isolated from sham-operated animals. Nevertheless, presence of propranolol augmented the hypertrophic effect of norepinephrine in both animals with aortic banding and sham-operated animals (Table 2B) .
DISCUSSION
Main findings of this study. The central question of this study was whether simultaneous stimulation of ␤-adrenoceptors can modulate the hypertrophic response to ␣ 1 -adrenoceptor stimulation on adult ventricular cardiomyocytes. The results of the present study show that ␤ 1 -adrenoceptor stimulation attenuates all investigated hypertrophy-related effects of ␣ 1 -adrenoceptor stimulation. Phenylalanine incorporation was determined for a oneday period. The changes described here in phenylalanine incorporation were paralleled by similar changes in cellular protein mass, indicating that they primarily represent changes in protein synthesis. Analogous considerations apply to changes in uridine incorporations that are accompanied by changes in RNA mass. In addition, cell volume and cross-sectional areas of the cells also increased, indicating hypertrophic growth of the cardiomyocytes. Intracellular signals involved in the ␤-adrenoceptormediated inhibitory effect. In the present study, in adult rat ventricular cardiomyocytes, ␤ 1 -adrenoceptor stimulation attenuated the hypertrophic response to ␣ 1 -adrenoceptor stimulation. This conclusion is based on the following findings: a) The hypertrophic response to norepinephrine is enhanced by ␤ 1 -adrenoceptor blockade by CPG 20712A or atenolol, but not affected by the highly selective ␤ 2 -adrenoceptor antagonist ICI 118,551; b) the hypertrophic response to the ␣ 1 -adrenoceptor agonist phenylephrine is significantly inhibited by isoprenaline in the presence of ICI 118,551 acting under these conditions solely at ␤ 1 -adrenoceptors. This inhibitory effect of ␤ 1 -adrenoceptor stimulation involves the cyclic-AMP-dependent protein kinase (PKA) system: thus, dibutyryl-cyclic-AMP can mimic the inhibitory effects of ␤ 1 -adrenoceptor stimulation on phenylephrine-induced increase in rate of protein synthesis; moreover, the PKA-inhibitor Rp-cAMPS significantly enhanced norepinephrine-evoked increase in protein synthesis and abolished ␤ 1 -adrenoceptor-mediated inhibition of phenylephrine-induced increases in rate of protein synthesis. Thus, taken together, in adult rat ventricular cardiomyocytes the hypertrophic response to norepinephrine is composed of two components: an ␣ 1 -adrenoceptormediated stimulation and a ␤ 1 -adrenoceptor-mediated inhibition. The ␤ 1 -adrenoceptor-induced inhibition of 
